Paper90177
Light microscopic stereological analysis of the normal human prostate and of benign prostatic hyperplasia.
Bartsch G and 3 others. J Urol, 1979. Cited by 237 papers, by iCite.
Cite this record
ConductScience Library. Light microscopic stereological analysis of the normal human prostate and of benign prostatic hyperplasia. Papers, record 90177. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/90177
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Light microscopic stereological analysis of the normal human prostate and of benign prostatic hyperplasia.
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Prostate | Major topic |
| Prostatic Hyperplasia | Major topic |
| Adult | |
| Cell Nucleus | |
| Cytological Techniques | |
| Humans | |
| Male | |
| Models, Biological |
Source PubMed
Cited by29
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 237 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41832222 | A single cell transcriptional profile of benign prostatic hyperplasia. | Sci Rep | 2026 | https://conductscience.org/library/papers/41832222 | PubMed |
| 41288675 | [Acute urinary retention]. | Urologie | 2026 | https://conductscience.org/library/papers/41288675 | PubMed |
| 39421674 | Bioassay-guided isolation of two antiproliferative metabolites from Pterocarpus indicus Willd. against TGF-β-induced prostate stromal cells (WPMY-1) proliferation via PI3K/AKT signaling pathway. | Front Pharmacol | 2024 | https://conductscience.org/library/papers/39421674 | PubMed |
| 37916442 | New therapeutic targets to prevent benign prostatic enlargement and symptomatic progression to benign prostatic obstruction-ICI-RS 2023. | Neurourol Urodyn | 2024 | https://conductscience.org/library/papers/37916442 | PubMed |
| 35268367 | Efficacy and Safety of the Sandwich Method in Patients with Benign Prostate Hyperplasia: Bipolar Transurethral Resection with GreenLight Vaporization. | J Clin Med | 2022 | https://conductscience.org/library/papers/35268367 | PubMed |
| 33737570 | Oxytocin receptor antagonists as a novel pharmacological agent for reducing smooth muscle tone in the human prostate. | Sci Rep | 2021 | https://conductscience.org/library/papers/33737570 | PubMed |
| 31094703 | Genomic analysis of benign prostatic hyperplasia implicates cellular re-landscaping in disease pathogenesis. | JCI Insight | 2019 | https://conductscience.org/library/papers/31094703 | PubMed |
| 28328188 | Prostate specific antigen and acinar density: a new dimension, the "Prostatocrit". | Int Braz J Urol | 2017 | https://conductscience.org/library/papers/28328188 | PubMed |
| 24454597 | The relationship between bladder wall thickness and lower urinary tract symptoms: Does bladder wall thickness change after alpha-blocker therapy with alfuzosin? | Can Urol Assoc J | 2014 | https://conductscience.org/library/papers/24454597 | PubMed |
| 23872639 | Age-related changes in the innervation of the prostate gland: implications for prostate cancer initiation and progression. | Organogenesis | 2013 | https://conductscience.org/library/papers/23872639 | PubMed |
| 23852618 | Age-related histological and zinc content changes in adult nonhyperplastic prostate glands. | Age (Dordr) | 2014 | https://conductscience.org/library/papers/23852618 | PubMed |
| 22474290 | Increased infiltrated macrophages in benign prostatic hyperplasia (BPH): role of stromal androgen receptor in macrophage-induced prostate stromal cell proliferation. | J Biol Chem | 2012 | https://conductscience.org/library/papers/22474290 | PubMed |
| 18231614 | Alpha blockers for the treatment of benign prostatic hyperplasia. | Rev Urol | 2007 | https://conductscience.org/library/papers/18231614 | PubMed |
| 17215999 | The evolution of alpha-blockers for the treatment of benign prostatic hyperplasia. | Rev Urol | 2006 | https://conductscience.org/library/papers/17215999 | PubMed |
| 16985970 | A Primary Care Physician's Perspective on Benign Prostatic Hyperplasia. | Rev Urol | 2003 | https://conductscience.org/library/papers/16985970 | PubMed |
| 16985855 | Evaluating men with benign prostatic hyperplasia. | Rev Urol | 2004 | https://conductscience.org/library/papers/16985855 | PubMed |
| 16465187 | Alpha1-, alpha2- and beta-adrenoceptors in the urinary bladder, urethra and prostate. | Br J Pharmacol | 2006 | https://conductscience.org/library/papers/16465187 | PubMed |
| 12882718 | The role of combination therapy for lower urinary tract symptoms secondary to benign prostatic hyperplasia. | Curr Urol Rep | 2003 | https://conductscience.org/library/papers/12882718 | PubMed |
| 12084322 | The clinical role of alpha-blockers in the treatment of benign prostatic hyperplasia. | Curr Urol Rep | 2000 | https://conductscience.org/library/papers/12084322 | PubMed |
| 10369476 | Mitogenic activation of human prostate-derived fibromuscular stromal cells by bradykinin. | Br J Pharmacol | 1999 | https://conductscience.org/library/papers/10369476 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/90177
GET https://conductscience.org/api/papers/v1/90177/cited_by?page=2